DOPING CONTROL IN MALE SOCCER PLAYERS IN BRAZIL: 10 YEARS OF FOLLOW-UP.

IF 0.5 4区医学 Q4 ORTHOPEDICS

Acta Ortopedica Brasileira Pub Date : 2024-03-22 eCollection Date: 2024-01-01 DOI:10.1590/1413-785220243201e273282

Herman Fabian Moscovici, Paulo Henrique Schmidt Lara, Fernando Antonio Gaya Solera, Moisés Cohen, Jorge Roberto Pagura, Gustavo Gonçalves Arliani

{"title":"DOPING CONTROL IN MALE SOCCER PLAYERS IN BRAZIL: 10 YEARS OF FOLLOW-UP.","authors":"Herman Fabian Moscovici, Paulo Henrique Schmidt Lara, Fernando Antonio Gaya Solera, Moisés Cohen, Jorge Roberto Pagura, Gustavo Gonçalves Arliani","doi":"10.1590/1413-785220243201e273282","DOIUrl":null,"url":null,"abstract":"Objective: To understand the Adverse Analytical Finding (AAF) that have occurred in Brazilian soccer in a recent 10-year period, comparing them to international data, to know the Brazilian profile.Methods: A review of the AAR in the Doping Control Commission database of the Brazilian Football Association from 2008 to 2017. The AAR in professional male soccer players between 2008 and 2017 were considered.Results: The sample selected in this research was composed of 40,092 doping tests, with 113 AAR, identified in 18 different competitions (0.28%) in the professional category, in Brazilian national and state competitions between 2008 and 2017, flagged in doping control exams through urine samples. Stimulants were detected most frequently (31.0%), followed by glucocorticoids (21.2%), diuretics, and masking agents (19.5%). The Brazilian Championship series did not show a relationship with any of the World Anti-Doping Agency (WADA) groups of substances. Series A showed 0.07% of AAR, Series B 0.21%, Series C 0.75% and Series D 1.49.Conclusion: The rate of AAR in Brazilian soccer was 0.28%, lower than the average for all soccer worldwide, and shows similar percentages among field positions. Stimulants were the most prevalent drugs. The national elite soccer competitions showed significantly fewer cases than the lower divisions. Level of Evidence II; Retrospective Study.","PeriodicalId":55563,"journal":{"name":"Acta Ortopedica Brasileira","volume":"32 1","pages":"e273282"},"PeriodicalIF":0.5000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962063/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Ortopedica Brasileira","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1413-785220243201e273282","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To understand the Adverse Analytical Finding (AAF) that have occurred in Brazilian soccer in a recent 10-year period, comparing them to international data, to know the Brazilian profile.

Methods: A review of the AAR in the Doping Control Commission database of the Brazilian Football Association from 2008 to 2017. The AAR in professional male soccer players between 2008 and 2017 were considered.

Results: The sample selected in this research was composed of 40,092 doping tests, with 113 AAR, identified in 18 different competitions (0.28%) in the professional category, in Brazilian national and state competitions between 2008 and 2017, flagged in doping control exams through urine samples. Stimulants were detected most frequently (31.0%), followed by glucocorticoids (21.2%), diuretics, and masking agents (19.5%). The Brazilian Championship series did not show a relationship with any of the World Anti-Doping Agency (WADA) groups of substances. Series A showed 0.07% of AAR, Series B 0.21%, Series C 0.75% and Series D 1.49.

Conclusion: The rate of AAR in Brazilian soccer was 0.28%, lower than the average for all soccer worldwide, and shows similar percentages among field positions. Stimulants were the most prevalent drugs. The national elite soccer competitions showed significantly fewer cases than the lower divisions. Level of Evidence II; Retrospective Study.

查看原文本刊更多论文

巴西男子足球运动员的兴奋剂控制：10 年的跟踪调查。

目的了解近十年来巴西足球运动中出现的阳性分析结果（AAF），并将其与国际数据进行比较，以了解巴西的概况：对 2008 年至 2017 年巴西足协兴奋剂控制委员会数据库中的阳性检测结果进行回顾。结果：本研究选取的样本由巴西足球协会兴奋剂控制委员会数据库中 2008 年至 2017 年的 AAR 数据组成：本研究选取的样本由 40 092 次兴奋剂检测组成，其中有 113 次 AAR，是在 2008 年至 2017 年间巴西国家级和州级比赛的 18 场不同比赛中（0.28%），通过尿样在兴奋剂检查中发现的。兴奋剂检出率最高（31.0%），其次是糖皮质激素（21.2%）、利尿剂和掩蔽剂（19.5%）。巴西锦标赛系列没有显示出与世界反兴奋剂机构（WADA）的任何一组物质有关系。A 系列的 AAR 含量为 0.07%，B 系列为 0.21%，C 系列为 0.75%，D 系列为 1.49%：巴西足球运动员的 AAR 感染率为 0.28%，低于全球足球运动员的平均水平，各位置球员的 AAR 感染率相近。兴奋剂是最常见的药物。全国精英足球比赛中的病例明显少于低级别联赛。证据等级 II；回顾性研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Ortopedica Brasileira Orthopedics-

CiteScore

0.90

自引率

14.30%

发文量

审稿时长

25 weeks

期刊介绍： A Revista Acta Ortopédica Brasileira, órgão oficial do Departamento de Ortopedia e Traumatologia da Faculdade de Medicina da Universidade de São Paulo (DOT/FMUSP), é publicada bimestralmente em seis edições ao ano (jan/fev, mar/abr, maio/jun, jul/ago, set/out e nov/dez) com versão em inglês disponível nos principais indexadores nacionais e internacionais e instituições de ensino do Brasil. Sendo hoje reconhecidamente uma importante contribuição para os especialistas da área com sua seriedade e árduo trabalho para as indexações já conquistadas.